Topic: Macrophages

Smallstorm uses military analogies to describe the body's immune response, where different "battalions" of cells like neutrophils and macrophages address cellular damage. If the primary inflammatory process fails to resolve oxidative stress, the body calls in bacteria and fungi to decompose organic debris. Sepsis is described as a state where bacterial waste products overwhelm the bloodstream, necessitating the use of antibiotics.

The conversation covers the evolution of the Human Genome Project and the rise of private companies like 23andMe. Agnew explains how DARPA-funded research into targeted cures using macrophages also has a dark side involving the development of genetic weaponry. He expresses concern that this technology could be used for limited genocide by targeting specific racial or geographic markers.

The biological process of chemotaxis is detailed, involving a sequence of "eater cells" like phagocytes and macrophages that digest injured tissue. Lymphocytes then follow to regenerate tissue using nutrients from the blood. When this process is impeded by modern medical interventions, an overabundance of dead organic debris attracts opportunistic fungi and bacteria to act as decomposers.

David Noakes explains that GCMAF is a naturally occurring human protein discovered 25 years ago by Dr. Yamamoto. He describes a 22-step extraction process and details laboratory experiments where GCMAF activates macrophages to consume human breast cancer cells within three days. Noakes claims the protein can treat 50 different diseases and has been the subject of 200 peer-reviewed scientific papers.